Mindento Competitors

Scale’s mission is to develop reliable AI systems for the world’s most important decisions. We provide the high-quality data and full-stack technologies that power the world’s leading models, and help enterprises and governments build, deploy, and oversee AI applications that deliver real impact. The Scale Generative AI Platform allows customers to build, evaluate, and control advanced AI agents and applications that continuously improve. The Scale Data Engine provides the technology to collect, curate, and annotate high-quality datasets. Through our Scale Labs, we test models with rigorous benchmarks and novel research to ensure breakthroughs translate into systems people can trust. Scale powers the most advanced LLMs and generative models in the world through RLHF, data generation and model evaluation. We work with industry leaders like Meta, Cisco, DLA Piper, Mayo Clinic, Time Inc., the Government of Qatar, and U.S. government agencies including the Army and Air Force.

Cerebral is setting a new standard of quality in integrated mental healthcare for over 100 million commercial insurance members by seamlessly providing therapy and psychiatry in a single point of access including delivery of medications. Our diverse, national network of clinicians train and certify in the Resilience Methodology, which has proven superior clinical outcomes, and delivers relief from symptoms, while equipping clients with abilities to successfully cope with challenges in the future. Getting the care you need is simple with Cerebral. Connect with your care team via virtual sessions complemented by direct, asynchronous messaging. If prescribed, medications can be delivered directly to your door. Learn more at www.cerebral.com.

Ada is pioneering a new way of patient finding — meeting people at the moment they search for answers and guiding them to the right care faster. Built by doctors and scientists, Ada’s Clinical AI is regulated as a Class IIa medical device in the EU. Our assessments are more than symptom checks — they enable partners to identify underdiagnosed patients, accelerate time-to-diagnosis, and measure real-world outcomes. Pharma organizations use Ada to engage patients earlier in their journey and connect them to the therapies they need. Health systems and insurers leverage Ada to route patients to appropriate care and surface underutilized benefits. With 13 million users worldwide and over 32 million assessments completed, Ada is trusted globally to transform uncertainty into action.